Pay in 4 interest-free payments of $5.30 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Retatrutide is currently classified as an Investigational New Drug (IND) , meaning it has not yet been approved by regulatory authorities
Getting the dilution right matters because incorrect reconstitution leads to inaccurate dosing, which undermines the entire dose escalation schedule
A TD Cowen analyst said to Reuters that the current status quo lets compounders create copycat drugs if they make minor tweaks they claim benefit specific patient groups, leaving the door pretty wide open. All of this lands as Novo already faces pricing and patent pressure
References 1.Nauck MA, et al
US$ 20.67
US$ 28.53
US$ 24.03
US$ 22.09
US$ 20.67
US$ 23.74
US$ 24.73
US$ 22.39
